Navigation Links
Celsion Completes Enrollment in Phase I Liver Cancer Study

dy of patients with recurrent breast cancer on the chest wall under the care of Dr. Kim Blackwell, the principal investigator.

About Celsion: Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems.

Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Cleveland Clinic, North Shore Long Island Jewish Health System.

Celsion has also developed a microwave based system, the Prolieve Thermodilatation(R) system, for the treatment of benign prostatic hyperplasia which is marketed in the United States under an exclusive distribution agreement with Boston Scientific Corporation. For more information on Celsion, visit our website: http://www.celsion.com.

Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

NO ENDORSEMENT OF CELSION CORPORATION OR ANY OF ITS PRODUCTS OR SERVICES BY THE NATIONAL INSTITUTES OF HEALTH OR THE CLINICAL CENTER IS INTENDED OR SHOULD BE INFERRED.

Contact

Celsion Corporation
Tony Deasey, 410-290-5390
tony@celsion.com
or
General
'"/>




Page: 1 2 3

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
3. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
4. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
5. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Celsion Completes Enrollment Phase Liver Cancer Study
(Date:12/2/2009)...AM, Mass. and NEW YORK, Dec. 2 /PRNewswire-FirstCa... ) and NYU Langone Medical Center announced findin...ke University on the genetics of osteoarthritis ha...version of the Annals of Rheumatic Diseases and is....2009.113043v1.pdf . Results from the study hi...
(Date:12/2/2009)...LE, Md., Dec. 2 Novavax,...itial results from the first stage of a two-stage ...mmunogenicity of the company,s 2009 H1N1 virus-lik...vax is conducting this study in collaboration with...tion of the vaccine in Mexico and potentially othe...
(Date:12/2/2009)...HAM, Ala., Dec. 2 Adults are mor...th cancer. For adults 65 and over, the odds of los... man developing prostate cancer are one in six and...in nine. Vision loss threatens the overall health...s, depression and inability to complete daily task...
Breaking Medicine Technology:Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 1Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 2Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 3Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 4Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 5Air Quality Action Day Forecast for July 16 in Philadelphia Region 51844 1Air Quality Action Day Forecast for July 16 in Philadelphia Region 51844 2AMN Healthcare Names New Chief Financial Officer 51839 1AMN Healthcare Names New Chief Financial Officer 51839 2AMN Healthcare Names New Chief Financial Officer 51839 3
...nternational,Inc. (Nasdaq: DATA ), a technology a...lutions for the clinical trials industry, reported... safety studies from six clinical,trial sponsors, ...earch, a,business unit of Duke Medical Strategies,... expected to be approximately $800,000. Four of th...
...ious Diseases Highlights Critical Need for ... BETHESDA, Md., Feb. 27 In response to recent da...ersonnel have received their,annual influenza vacc...seases (NFID) has published two new reports: a Cal...e annual influenza vaccines and a Best,Practices r...
Other Medicine Technology:DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 2DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 3DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 4DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 5Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal 2Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal 3
(Date:12/2/2009)...s popular among youths are more likely to be adver... alcoholic drinks consumed mainly by adults, resul...such targeted alcohol ads, according to a new stud... of Public Health, Johns Hopkins Bloomberg School ...conducted the study -- published in this month,s ...
(Date:12/2/2009)...e unlikely heroes in the battle against drug abuse...ready used to study dozens of human disease could...uit flies can be used as a simpler and more conven...ine and other drugs of abuse on the brain. Their s..., a new monthly journal. , Andrew Ewing and col...
(Date:12/2/2009)... flies get high cholesterol and become obese? The ... rich in fats. , More importantly, according to ...geneticist, fruit flies use the same molecular mec... of cholesterol and a key form of stored fat that ...researchers try to learn more about the genetic an...
(Date:12/2/2009)...S Technology and ASML Receive Innovation Awards in...la. (PRWEB) December 2, 2009 -- ILS Technology, LL...ough connectivity, today announced that the compan...d with awards for technical innovation to the indu...rnational Society of Automation (ISA) named ILS Te...
(Date:12/2/2009)... 2 Holly Potter, vice president, P...nagement for Kaiser Permanente, received the "PR T... held at the National Press Club. ,, PR News...innovators and professionals who day in and day ou...ace. The winners of this year,s program set the be...
Breaking Medicine News(10 mins):Health News:Alcohol companies target youths with magazine ads, new study shows 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:ILS Technology and Customer ASML Recipients of Industry Recognition Awards 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3
...y of its kind, researchers at UCLA have confirmed ...n as cytokines as a cause of Type 2 diabetes, and ...biological markers that may be used to more accura...al Medicine, Simin Liu, professor of epidemiology ...
...anemia be used to assess the burden and control of...acogenomics: challenges on the road to the clinic,...nd use the links below to take your readers straig...al diseases" , In this week,s PLoS Medicine, a t...
...ell us when middle-aged spread is getting out of h...the ready. New research shows that adding several ... within a normal rangemarkedly increases the risk ... Medical Center in Dallas, appears in the August 2...
...ed to prevent cluster headaches can cause heart pr...st 14, 2007, issue of Neurology, the medical journ...ing the drug verapamil for cluster headaches shoul...e form of headache that is more common in men. The...
...higher risk of developing late age-related macular...cording to a report in the July issue of Archives ...s. , Age-related macular degeneration (AMD) [a p... information in the article. In addition to smokin...
..., causing structural damage to DNA, players in two...tain the wreckage, scientists at The University of...August edition of Cell. , This connection between...lly attacking cancer," says senior author Xuetong ...
Other Medicine News:Health News:UCLA researchers identify markers that may predict diabetes in still-healthy people 2Health News:UCLA researchers identify markers that may predict diabetes in still-healthy people 3Health News:Anemia and tropical diseases; Is pharmacogenomics ready for the clinic? 2Health News:Pot bellies linked to early signs of cardiovascular disease 2Health News:Pot bellies linked to early signs of cardiovascular disease 3Health News:Drug for cluster headaches may cause heart problems 2Health News:Smoking may strongly increase long-term risk of eye disease 2Health News:Chromatin remodeling complex connected to DNA damage control 2
FM Series Flowmeters - Oxygen Power Take Off
...for the Anterior Segment The BD is optimized for ...ers and ophthalmologists specializing in the anter...ist within emergency rooms. Video- c-mount camera ...deo port. Standard magnification in 10 and 16 X ti...
... that makes it all possible,Open. Automated. Acc...ation is an automated multi-purpose instrument tha...s in the analysis of Single Nucleotide Polymorphis...e NanoChip Electronic Microarray. The unique, open...
Eppendorf Filtertips, 250 l, sterile, and PCR Clean
Medicine Products: